XBiotech Inc.
XBIT
$2.81
-$0.10-3.44%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -39.41M | -38.53M | -32.66M | -35.01M | -30.74M |
| Total Depreciation and Amortization | 1.76M | 1.75M | 1.74M | 1.73M | 1.73M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.36M | 7.28M | 2.00M | 4.36M | 3.01M |
| Change in Net Operating Assets | -1.19M | -1.46M | 1.07M | 5.42M | 4.88M |
| Cash from Operations | -30.48M | -30.96M | -27.86M | -23.50M | -21.12M |
| Capital Expenditure | -1.14M | -1.30M | -1.34M | -1.03M | -611.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 61.86M | 61.86M |
| Cash from Investing | -1.14M | -1.30M | -1.34M | 60.83M | 61.25M |
| Total Debt Issued | 250.00K | 10.25M | 10.00M | 10.00M | 10.00M |
| Total Debt Repaid | -10.25M | -- | -- | -- | -- |
| Issuance of Common Stock | 145.00K | 200.00K | 167.00K | 108.00K | 60.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | -14.00K |
| Cash from Financing | -9.86M | 10.45M | 10.17M | 10.11M | 10.05M |
| Foreign Exchange rate Adjustments | -3.66M | -5.53M | -49.00K | -2.30M | -1.62M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -45.14M | -27.35M | -19.07M | 45.14M | 48.56M |